EpiBiologics launched in 2023 with a $50 million series A, having been founded to take forward the work of renowned antibody ...

The deal hands Amgen a drug that destroys two proteins known to drive certain types of acute myeloid leukemia, a profile that ...

The team brings a strong balance of scientific and commercial expertise, has built a unique data foundation with a ...

Krystal Biotech (NASDAQ:KRYS) said it has generated positive interim clinical results for its inhaled cystic fibrosis (CF) ...

Amgen is adding Dark Blue to its tapestry, embedding the U.K. biotech’s preclinical blood cancer program into its ...

Confirmed wild-type CFTR delivery and expression in conducting airway cells of patients with class I mutationsKB407 transduction confirmed in all ...

GenScript Biotech Corporation, a global leader in life sciences R&D and manufacturing services, is proud to announce its 5th Annual Biotech Global Forum, scheduled for January 14, 2026, at the San ...

VERONA, Italy--(BUSINESS WIRE)--Sibylla Biotech today announced the successful close of its €23 million Series A financing round to fund the further development of its Pharmacological Protein ...

Kymera Therapeutics, a preclinical biotech developing small molecule protein degrader therapies for immunology-inflammation and oncology, filed on Friday with the SEC to raise up to $100 million in an ...

The companies Kymera Therapeutics, Immunovant, and Dyne Therapeutics bagged the biggest biotech funding rounds overall in ...